Igor Bado, PhD
img_Igor Bado
ASSISTANT PROFESSOR | Oncological Sciences
Research Topics
Breast Cancer, Cancer, Epigenetics, Metastasis
Multi-Disciplinary Training Area
Cancer Biology [CAB]
New topic
Dr. Bado studies how different tumor microenvironments crosstalk with cancer cells to promote survival, growth, and secondary spread to other organs. His goal is to understand epigenetic implications in cancer cell adaptation, intra-tumoral heterogeneity, and multi-organ metastasis. He believes that epigenetic factors -which modulate gene expression, are key players in the metastatic process and can be targeted to reprogram cancer cells toward improved therapeutic responses. Ultimately, he aims to identify therapeutic vulnerabilities for the long-term remission of metastatic diseases. He uses state-of-the-art approaches to dissect the mechanisms driving breast cancer metastasis from the early dissemination of CTCs to the formation of macro-metastases in advanced stages of the disease.

BSc, University of Ouagadougou

PhD, University of Houston

Postdoctoral, Baylor College of Medicine

2022

Biomedical Laureate

Icahn School of Medicine at Mount Sinai

2022

Dean’s Award of Excellence

Baylor College of Medicine

2022

NCI Pathway to Independence Award (K99/R00)

National Cancer Institute

2021

SPORE-Breast Center Career Enhancement Program Awardee

Baylor College of Medicine

Publications

Selected Publications

The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research. Hillary S. Andrews, Igor L. Bado, Amy Beumer, Isaac S. Chan, Janice Cowden, Debbie Denardi, Gloria V. Echeverria, Brooke L. Gates, Marybeth Gilliam, Christine Hodgdon, Adrian V. Lee, Joan Mancuso, Julia Maues, Steffi Oesterreich, Michael Papanicolaou, Katherine E. Pendleton, Bob Riter, Kelly Shanahan, Anh M. Tran-Huynh, Pavitra Viswanath, Stephanie Walker, Alana L. Welm, Michelle M. Williams, Garhett L. Wyatt, Josh Newby. npj Breast Cancer

Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer. Liqun Yu, Keziah Liebenberg, Yichao Shen, Fengshuo Liu, Zhan Xu, Xiaoxin Hao, Ling Wu, Weijie Zhang, Hilda L. Chan, Bo Wei, Philip L. Lorenzi, Yang Gao, Igor Bado, Luis Becerra-Dominguez, Charlotte Helena Rivas, Sergio Aguirre, Bradley C. Pingel, Yi Hsuan Wu, Yunfeng Ding, Jun Liu, David G. Edwards, Livia S. Eberlin, Xiang H.F. Zhang. Immunity

Bone-Induced HER2 Promotes Secondary Metastasis in HR<sup>+</sup>/HER2<sup>−</sup> Breast Cancer. Rahat Alam, Anna Reva, David G. Edwards, Bree M. Lege, Laura S. Munoz-Arcos, Carolina Reduzzi, Swarnima Singh, Xiaoxin Hao, Yi Hsuan Wu, Zeru Tian, Laura M. Natalee, Gargi Damle, Deniz Demircioglu, Yixian Wang, Ling Wu, Elisabetta Molteni, Dan Hasson, Bora Lim, Zbigniew Gugala, Jerry E. Chipuk, Julie E. Lang, Joseph A. Sparano, Chonghui Cheng, Massimo Cristofanilli, Han Xiao, Xiang H.F. Zhang, Igor L. Bado. Cancer Discovery

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Bado during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Endocrine Society

Editorial Services

  • npj Precision Oncology
  • FASEB

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.